Steven Cohen’s Sarepta Therapeutics SRPT Stock Holding History

Steven Cohen’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,000	Closed	-$675K	–	4555
2026 Q1	$675K	Buy	+31,000	New	+$600K	﹤0.01%	2988
2025 Q4	–	Sell	-145,000	Closed	-$2.79M	–	4160
2025 Q3	$2.79M	Buy	145,000 +95,000	+190%	+$1.69M	﹤0.01%	1310
2025 Q2	$855K	Buy	50,000 +20,000	+67%	+$853K	﹤0.01%	1608
2025 Q1	$1.91M	Buy	+30,000	New	+$3.16M	﹤0.01%	1258
2023 Q4	–	Sell	-33,000	Closed	-$4M	–	2772
2023 Q3	$4M	Buy	+33,000	New	+$3.73M	0.01%	953
2022 Q1	–	Sell	-16,500	Closed	-$1.49M	–	1381
2021 Q4	$1.49M	Buy	+16,500	New	+$1.41M	0.01%	859
2019 Q2	–	Sell	-200,000	Closed	-$23.8M	–	1515
2019 Q1	$23.8M	Buy	+200,000	New	+$25.7M	0.11%	214
2018 Q2	–	Sell	-100,000	Closed	-$7.41M	–	1169
2018 Q1	$7.41M	Sell	100,000 -100,000	-50%	-$6.67M	0.03%	492
2017 Q4	$11.1M	Buy	+200,000	New	+$10.6M	0.05%	424
2017 Q1	–	Sell	-100,000	Closed	-$2.74M	–	946
2016 Q4	$2.74M	Sell	100,000 -150,000	-60%	-$6.02M	0.02%	524
2016 Q3	$15.4M	Hold	250,000	–	–	0.11%	225
2016 Q2	$4.77M	Buy	+250,000	New	+$4.63M	0.03%	434
2016 Q1	–	Sell	-380,200	Closed	-$14.7M	–	836
2015 Q4	$14.7M	Buy	+380,200	New	+$12.3M	0.12%	205
2015 Q3	–	Sell	-174,900	Closed	-$5.32M	–	891
2015 Q2	$5.32M	Hold	174,900	–	–	0.04%	436
2015 Q1	$2.32M	Sell	174,900 -100,300	-36%	-$1.34M	0.02%	545
2014 Q4	$3.98M	Sell	275,200 -416,000	-60%	-$7.04M	0.03%	470
2014 Q3	$14.6M	Buy	+691,200	New	+$15.6M	0.11%	225

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steven Cohen's SRPT Position: Q2 2026 in Review

Steven Cohen opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 510,908 shares worth $9.18M. The stake represents 0.01% of the portfolio and ranks #1340 among its holdings. This is a return to the name: Steven Cohen previously reported a position in SRPT as recently as Q4 2025.

Steven Cohen first reported a position in SRPT in Q2 2014 and has held it in 36 quarters since. The position peaked at $202M in Q3 2016. 320 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Steven Cohen held 510,908 shares of Sarepta Therapeutics worth $9.18M as of Q2 2026.
Sarepta Therapeutics was a new Steven Cohen position in Q2 2026.
Sarepta Therapeutics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1340 holding.
Steven Cohen first reported a position in Sarepta Therapeutics in Q2 2014 and has held it in 36 quarters since.
Steven Cohen's Sarepta Therapeutics position peaked at $202M in Q3 2016.
320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.